Company Search:
Advanced Search
Sponsored Links
Shenzhen Neptunus Bioengineer Company Snapshot
Shenzhen Neptunus Bioengineer operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Neptunus Bioengineer with three other companies in this sector in China: Beijing Tongrentang Co., Ltd. (2015 sales of 10.79 billion Chinese Renmimbi [US$1.57 billion] of which 51% was Manufacturing), Humanwell Healthcare Group Co Ltd (10.05 billion Chinese Renmimbi [US$1.46 billion] of which 99% was Medication & Health Products), and Shandong Buchang Pharmaceuticals Co Ltd (11.65 billion Chinese Renmimbi [US$1.69 billion] of which 88% was Pharmaceutical Business).

Sales Analysis. During the year ended December of 2015, sales at Shenzhen Neptunus Bioengineer were 11.12 billion Chinese Renmimbi (US$1.61 billion). This is an increase of 13.4% versus 2014, when the company's sales were 9.80 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shenzhen Neptunus Bioengineer (and since 2010, sales have increased a total of 178%). Sales of Other Operating saw an increase that was more than double the company's growth rate: sales were up 106.6% in 2015, from 17.14 million Chinese Renmimbi to 35.40 million Chinese Renmimbi. Shenzhen Neptunus Bioengineer also saw significant increases in sales in Pharmaceutical Appliance (up 37.9% to 645.61 million Chinese Renmimbi) . Not all segments of Shenzhen Neptunus Bioengineer experienced an increase in sales in 2015: sales of Pharmaceutical Manufacturing fell 27.9% to 477.68 million Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Shenzhen Neptunus Bioengineer
  Stock Performance Chart for Shenzhen Neptunus Bioengineer
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 6.39
(Figures in Chinese Renmimbi)
1 Week -1.4%   13 Weeks -3.6%  
4 Weeks 0.0%   52 Weeks -4.3%  
Shenzhen Neptunus Bioengineer Key Data:
  Ticker: 000078 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 11,115,466,795
(Year Ending Jan 2016).
Employees: 4,502
  Currency: Chinese Renmimbi Market Cap: 16,590,265,987
  Fiscal Yr Ends: December Shares Outstanding: 2,596,285,757
  Share Type: A Gu Closely Held Shares: 1,250,678,645
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.